Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
University of Massachusetts Medical School
Worcester, Estados UnidosPublicacións en colaboración con investigadores/as de University of Massachusetts Medical School (11)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 10, pp. 725-734
2020
2017
-
Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance
Cell Metabolism, Vol. 26, Núm. 1, pp. 212-229.e12
2016
-
Genomic insights into the Ixodes scapularis tick vector of Lyme disease
Nature Communications, Vol. 7
-
Hydrophobic CDR3 residues promote the development of self-reactive T cells
Nature Immunology, Vol. 17, Núm. 8, pp. 946-955
2014
-
A unified nomenclature and amino acid numbering for human PTEN
Science Signaling, Vol. 7, Núm. 332
2013
2010
-
PKCζ-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance
Cell Metabolism, Vol. 12, Núm. 1, pp. 65-77
2007
-
Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130
Molecular and Cellular Biology, Vol. 27, Núm. 14, pp. 5161-5171